Mercia Fund Managers
Mercia Asset Management is a specialist asset manager based in the United Kingdom, focused on equity and debt investments to support the growth aspirations of regional businesses. The firm manages multiple funds, including venture capital funds dedicated to early-stage technology companies, particularly in the West Midlands. Mercia aims to provide a complete capital solution by investing across various asset classes, including venture and private equity. It emphasizes backing companies with strong growth potential and proprietary technology. The firm offers initial investments typically ranging from £50,000 to £250,000, with the capacity for follow-on investments up to £1 million per company. Mercia Asset Management also allows private investors to participate in high-growth technology companies through its Growth EIS Fund, benefiting from tax reliefs. Established in 1982, Mercia has established a reputation as a proactive partner for business owners, shareholders, and fund investors, aspiring to deliver superior returns.
Top Stages
Past deals in Birmingham
AdaptTech
Venture Round in 2022
AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.
AdaptTech
Venture Round in 2021
AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.
Irresistible Materials
Angel Round in 2018
Irresistible Materials Ltd is a materials technology company based in Swansea, United Kingdom, specializing in the development and commercialization of fullerene-based photoresist technology. Founded in 2010 as a spin-out from the University of Birmingham, the company collaborates with Nano-C Inc in the United States to create advanced materials for next-generation lithography applications. Irresistible Materials focuses on providing innovative solutions, including EUV resists, spin-on-carbon, and e-beam resists, aimed at meeting the demands of the semiconductor industry for increasingly smaller microchip feature sizes. The company has established a robust patent portfolio that encompasses various resist and hard-mask materials and maintains strong partnerships with the University of Birmingham and a network of global collaborators to further advance its materials offerings.
VoxPopMe
Series A in 2017
Voxpopme Limited is a Birmingham-based company that specializes in a video insight platform designed to facilitate direct interaction between brands and consumers. Founded in 2013, the company offers an application that allows businesses to pose questions to targeted consumer groups based on demographics such as age, gender, and location, in order to gather feedback through video responses. The platform enables companies to capture, analyze, and share consumer opinions efficiently, making it applicable for various uses, including customer experience surveys, brand tracking, market testing, and product development. With an additional office in Utah, United States, Voxpopme positions itself as a leader in the market research sector, providing tools that empower businesses to make informed decisions backed by authentic consumer narratives.
Health Centrified
Seed Round in 2017
Health Centrified, a Birmingham, UK-based developer of a communication platform which offers secure digital access to healthcare services.The company intends to use the funds to support the development, evaluation and commercialisation of its software platform.
AdaptTech
Seed Round in 2016
AdaptTech Ltd., established in 2015 and based in Birmingham, UK, is a biomedical company specializing in innovative, smart wearable technologies designed to enhance the lives of individuals with physical limitations, particularly those who have experienced lower limb loss. The company's flagship products include the INSIGHT Scanner, which rapidly creates a 3D model of prosthetic sockets; the INSIGHT Wearable, real-time bio-data tracker between the stump and socket; and the INSIGHT App, providing anytime access to results. AdaptTech aims to empower clinicians with improved socket fitting and monitoring methods, ultimately improving the quality of life for users.
Aston EyeTech
Seed Round in 2014
Aston EyeTech is a tech startup developing a range of proprietary hardware and software products for ocular care. It is revolutionizing the Ocular care ecosystem through increased portability, improved accuracy, and lower costs.
The company is a spinout from Aston University’s School of Optometry. Aston EyeTech was founded in 2014 and is based in Birmingham, England.
Celentyx
Seed Round in 2007
Celentyx is a contract research organization specializing in human immunology assays. It provides bespoke assay services to study the effects of small molecules and biological candidates on the human immune system, with capabilities in immuno-oncology, autoimmunity and inflammation, fibrosis, and neuroinflammation. The company uses an immuno-profiling platform to identify therapeutic targets and rapidly analyze drug action on human immune cells, supporting the development and reprofiling of immunotherapies. It offers rapid analysis of drug effects on immune tissues and cells and access to patient and healthy donor samples for high-resolution investigations. Through collaborations with leading research centers, Celentyx enables detailed investigation of immune function in health and disease, aiding researchers and clinicians in understanding mechanisms and accelerating therapeutic discovery and optimization in immunology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.